Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

Immune‐enhancing adjuvants usually targets antigen (Ag)‐presenting cells to tune up cellular and humoral immunity. CD141(+) dendritic cells (DC) represent the professional Ag‐presenting cells in humans. In response to microbial pattern molecules, these DCs upgrade the maturation stage sufficient to...

Descripción completa

Detalles Bibliográficos
Autores principales: Seya, Tsukasa, Shime, Hiroaki, Takeda, Yohei, Tatematsu, Megumi, Takashima, Ken, Matsumoto, Misako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714660/
https://www.ncbi.nlm.nih.gov/pubmed/26395101
http://dx.doi.org/10.1111/cas.12824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714660/
https://www.ncbi.nlm.nih.gov/pubmed/26395101
http://dx.doi.org/10.1111/cas.12824

Ejemplares similares